Post-exposure prophylaxis for sexual exposure to HIV

Current Opinion in Infectious Diseases

Volumn 17, Issue 1, 2004, Pages 39-40

  Pozniak, Anton ^a,b  

^a St Stephen's Centre   (United Kingdom)

^b St Stephen's Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AMINOTRANSFERASE BLOOD LEVEL; EDITORIAL; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TRANSPLANTATION; OCCUPATIONAL EXPOSURE; PREGNANCY; PROPHYLAXIS; RASH; SEXUAL TRANSMISSION; SHORT COURSE THERAPY; SIDE EFFECT; TREATMENT FAILURE; VIRUS TRANSMISSION; CHEMOPROPHYLAXIS; DISEASE TRANSMISSION; HEALTH CARE DELIVERY; SEXUAL BEHAVIOR; UNITED STATES;

ANTI-HIV AGENTS; CHEMOPREVENTION; DELIVERY OF HEALTH CARE; DISEASE TRANSMISSION, HORIZONTAL; HIV INFECTIONS; HUMANS; SEXUAL BEHAVIOR; UNITED STATES;

EID: 3042825578     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200402000-00007     Document Type: Editorial

References (17)

1. Tsai CC, Eman P, Follis KE, et al. Effectiveness of post-inoculation PMPA treatment for prevention of persistent SIV infection depends critically on timing of initiation and duration of treatment. J Virol 1998; 72:4265-4273.
2. Le Grand R, Vaslin B, Largero L, et al. Post-exposure prophylaxis with HAART could not protect macaques from inoculation with SIV/HIV chimera. AIDS 2000; 14:1846-1866.
3. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure to HIV-infected blood: clinical and public health implications. N Engl J Med 1997; 337:1485-1490.
4. Centres for Disease Control. Case-control study of HIV seroconversion in healthcare workers after percutaneous exposure to HIV-infected blood, France, United Kingdom and United States, January 1988-August 1994. MMWR 1995; 44:929.
5. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment and the risk of transmission of human immunodeficiency virus type-1 from mother to infant. N Engl J Med 1996; 335:1621-1629.
6. Wade NA, Birkhead GC, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998; 339:1409-1414.
7. Schechter M, Lago RF, Ismerio R, et al. Acceptability, behavioural impact, and possible efficacy of post sexual exposure chemoprophylaxis (PEP) for HIV. In: Programme and Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections. Seattle Washington, 24-28 February 2002 [Abstract 15].
8. Schechter M. Occupational and sexual PEP - benefit/risk? In: Programme and Abstracts of the 6th International Conference on Drug Therapy in HIV Infection. Glasgow, UK, 17-21 November 2002 [Abstract PL6.1].
9. Benn P, Mercey D, Brink N, et al. Post-exposure prophylaxis using a nevirapine based regimen. Lancet 2001; 357:687-688.
10. Parkin JM, Murphy M, Anderson J, et al. Tolerability and side-effects of post-exposure prophylaxis for HIV infection. Lancet 2000; 355:722-734.
11. Evans B, Duggan W, Baker J, et al. Exposure of healthcare workers in England, Wales, and Northern Ireland to blood borne viruses between 1997 and June 2000: analysis of surveillance data. BMJ 2001; 322:397-398.
12. Hecht FM, Grent RM, Petropoulos CJ, et al. Sexual transmission of an HIV-1 variant resistant to multiple reverse transcriptase and protease inhibitors. N Engl J Med 1998; 339:307.
13. Boden D, Hurley A, Zhang L, et al. HIV-1 drug resistance in newly infected individuals. JAMA 1999; 282:1135-1141.
14. Pillay D, UK Collaborative group on monitoring the transmission of HIV-drug resistance. Analysis of prevalence of HIV-1 drug resistance in primary infections in the UK. BMJ 2001; 322:1087-1088.
15. Yerly S, Kaiser L, Raie E, et al. Transmission of antiretroviral-drug resistance HIV-1 variants. Lancet 1999; 354:729-733.
16. Van der stratten A, Gomez CA, Saul L, et al. Sexual risk behaviours among heterosexual serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy. AIDS 2000; 14:F47-F54.
17. Waldo CR, Franses K, Dillon B. Innovative approaches to health psychology: prevention and treatment lessons from AIDS. In: Chesney MA, Antoni MH, editors. Washington ISBN 1-66796-913-3 APA Books: 2002.